Quoin Pharmaceuticals
QNRX
1 hedge funds and large institutions have $741K invested in Quoin Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
49% less capital invested
Capital invested by funds: $1.45M → $741K (-$705K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$602K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $412K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $207K | -$602K | -1 | Closed |
|
3
Morgan Stanley
New York
| $71K | – | – | – |
|
4
Citigroup
New York
| $46K | – | – | – |
|
|
APA
5
American Portfolios Advisors
Holbrook,
New York
| $4.76K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$11K | – | – |
|
QNRX Hedge Fund Activity: Q3 2018 in Review
1 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2018, worth a combined $741K — down 49% from $1.45M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of QNRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $602K sold.
- 1 institutional investor held Quoin Pharmaceuticals (QNRX) as of Q3 2018, down from 2 in Q2 2018.
- Funds reported $741K of Quoin Pharmaceuticals stock for Q3 2018, down 49% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q3 2018 and 1 closed out, a net change of -1 holder.
- The largest Quoin Pharmaceuticals seller in Q3 2018 was Susquehanna International Group, an estimated $602K sold.
Based on aggregated 13F filings for Q3 2018.